Literature DB >> 17211436

Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.

F Palandri, M Amabile, G Rosti, G Bandini, F Benedetti, E Usala, E Angelucci, M Tiribelli, R Fanin, G Martinelli, M Baccarani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17211436     DOI： 10.1038/sj.bmt.1705554

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.

Authors:  Sarah Schmidt; Ying Liu; Zhen-Huan Hu; Kirsten M Williams; Hillard M Lazarus; Ravi Vij; Mohamed A Kharfan-Dabaja; Guillermo Ortí; Peter H Wiernik; Daniel Weisdorf; Rammurti T Kamble; Roger Herzig; Baldeep Wirk; Jan Cerny; Ulrike Bacher; Naeem A Chaudhri; Sunita Nathan; Nosha Farhadfar; Mahmoud Aljurf; Usama Gergis; Jeffrey Szer; Sachiko Seo; Jack W Hsu; Richard F Olsson; Dipnarine Maharaj; Biju George; Gerhard C Hildebrandt; Vaibhav Agrawal; Taiga Nishihori; Hisham Abdel-Azim; Edwin Alyea; Uday Popat; Ronald Sobecks; Bart L Scott; Jennifer Holter Chakrabarty; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-14       Impact factor: 5.742

2.  Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.

Authors:  Daniel N Egan; Lan Beppu; Jerald P Radich
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-06       Impact factor: 5.742

3.  Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation.

Authors:  Hua Jin; Yiying Xiong; Jing Sun; Yu Zhang; Fen Huang; Hongsheng Zhou; Zhiping Fan; Dan Xu; Yongqiang Wei; Min Dai; Ru Feng; Qifa Liu
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

4.  Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Nira Varda-Bloom; Ivetta Danylesko; Roni Shouval; Shiran Eldror; Atar Lev; Jacqueline Davidson; Esther Rosenthal; Yulia Volchek; Noga Shem-Tov; Ronit Yerushalmi; Avichai Shimoni; Raz Somech; Arnon Nagler
Journal:  Oncotarget       Date:  2017-01-03

5.  The use of imatinib mesylate as a lifesaving treatment of chronic myeloid leukemia relapse after bone marrow transplantation.

Authors:  Monika Conchon; Sabri S Sanabani; Israel Bendit; Carla Luana Dinardo; Lucia Dias; Dalton de Alencar Fischer Chamone; Pedro Enrique Dorlhiac-Llacer; Frederico Luiz Dulley
Journal:  J Transplant       Date:  2009-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.